⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Aaron KuntzM.D.

Internal Medicine · Boston, MA 02215

NPI: 1053766931

Share:

38

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers90th percentile opioid prescribingHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

288

Total Claims

$19K

Drug Cost

50

Beneficiaries

$372

Cost/Patient

Risk Score Breakdown 38/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Long-acting opioid rate+8
Opioid rate (national percentile)+5

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

+1668%

Opioid rate vs peers

39.6% vs 2.2% avg

-74%

Cost per patient vs peers

$372 vs $1,411 avg

+24%

Brand preference vs peers

13.2% vs 10.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 1,668% above the average for Internal Medicine providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

39.6%

Opioid Rate

114

Opioid Claims

$15K

Opioid Cost

39.5%

Long-Acting Rate

This provider's opioid prescribing rate of 39.6% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

87% generic

Brand: 38 claims · $12K

Generic: 250 claims · $7,092

Patient Profile

71

Avg Age

44%

Female

2.83

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About